Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:06 PM
Ignite Modification Date:
2025-12-24 @ 9:06 PM
NCT ID:
NCT03592004
Eligibility Criteria:
Inclusion Criteria:
* biopsy-proven invasive breast cancer;
* received complete neoadjuvant chemotherapy and no treatment has been done before;
* surgery was performed after completion of neoadjuvant chemotherapy, after which pCR was confirmed by postoperative pathological examination;
* pretreatment MRI data within a month before the start of the treatment was eligible, including T2WI, DWI and DCE-MRI.
Exclusion Criteria:
* not completing neoadjuvant chemoradiotherapy;
* not undergoing surgery at our hospital, or pCR was not assessed;
* lack of T2WI, or DWI or DCE-MRI data;
* insufficient MRI quality to obtain measurements (e.g., owing to motion artifacts);
* had unilateral multifocal cancers, and the correlation between the tumor in MR images and postoperative pathological examination was uncertain.
Healthy Volunteers:
False
Sex:
FEMALE
Study:
NCT03592004
Study Brief:
Protocol Section:
NCT03592004